2022's første forelesning fra IFCN Masterclass by IFCN holdes den 15/1 2022.

Professor Ryusuke (Ricky) Kakigi will present:
Face Perception in Humans: Clinical Neurophysiological and Imaging Studies
MasterClass Ifcn

 

The Masterclass by IFCN presentations were created in response to a call from IFCN members societies for more high quality, complimentary, online educational content. The series will provide a new presentation every month from top clinical neurophysiologists around the world, and each will include time for discussion with the lecturer following the presentation.

Providing the best in contemporary clinical neurophysiology education delivered in the most optimal format is the primary educational goal of the IFCN. As such, Masterclass by IFCN will be available complimentary to all registrants.

 

The Masterclass by IFCN presentation:

"Face Perception in Humans: Clinical Neurophysiological and Imaging Studies"
on Saturday 15 January 2022 at 7:00 AM EST / 1:00 PM CEST, will be held by Professor Ryusuke (Ricky) Kakigi.

 

Prof Kakigi

Prof Kakigi.

 

Prof. Kakigi's team have been studying the underlying mechanisms of face perception in humans using magneto- (MEG), electroencephalography (EEG) and near-infrared spectroscopy (NIRS). In this lecture, Prof. Kakigi will mainly focus on development of face perception in infants. NIRS is a spectroscopic method using the near-infrared region of the electromagnetic spectrum (from 780 nm to 2500 nm). The biggest advantages of NIRS compared with functional magnetic resonance imaging (fMRI) are as follows: (1) NIRS can be used when subjects are moving, for example, during walking and cooking. Therefore, NIRS can be used for measuring brain activity of infants and children who cannot help moving. (2) It is much cheaper. Prof. Kakigi recently made a special light probe of NIRS for studying infants. This lecture will mainly introduce his basic studies of face perception in infants using NIRS. In addition, Prof. Kakigi will introduce his latest clinical studies in patients with attention deficit hyperactivity disorder (ADHD) and anorexia nervosa.

Register now 

 

 

logo ifcn